Sg3 Management, LLC Amarin Corp Plcuk Put Options Transaction History

Sg3 Management, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2022 May 16, 2022	BUY	$2.85 - $3.73 $51,300 - $67,140	18,000 Added 189.47%	27,500 $90,000
Q1 2021 May 17, 2021	SELL	$5.03 - $8.8 $163,475 - $286,000	-32,500 Reduced 77.38%	9,500 $59,000
Q4 2020 Feb 16, 2021	BUY	$4.04 - $5.31 $131,300 - $172,575	32,500 Added 342.11%	42,000 $205,000
Q2 2020 Aug 14, 2020	BUY	$4.78 - $8.26 $45,410 - $78,470	9,500 New	9,500 $66,000
Q1 2019 May 14, 2019	SELL	$12.61 - $22.33 $378,300 - $669,900	-30,000 Closed	0 $0
Q4 2018 Feb 12, 2019	BUY	$12.41 - $22.98 $372,300 - $689,400	30,000 New	30,000 $408,000

177

65.1M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $214M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.